Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366602743> ?p ?o ?g. }
- W4366602743 abstract "Abstract Novel promising strategies for combination with sorafenib are urgently needed to enhance its clinical benefit and overcome toxicity in hepatocellular carcinoma (HCC). the molecular and immunomodulatory antitumor effects of sorafenib alone and in combination with the new immunotherapeutic agent R848 are presented. Syngeneic HCC mouse model is presented to explore the antitumor effect and safety of three sorafenib doses alone, R848 alone, or their combination in vivo. R848 significantly enhances the sorafenib antitumor activity at a low subclinical dose with no obvious toxic side effects. Furthermore, the combination therapy reprograms the tumor immune microenvironment by increasing antitumor macrophages and neutrophils and preventing immunosuppressive signaling. Combination treatment promotes classical M1 macrophage‐to‐FTH1 high M1 macrophage transition. The close interaction between neutrophils/classical M1 macrophages and dendritic cells promotes tumor antigen presentation to T cells, inducing cytotoxic CD8 + T cell‐mediated antitumor immunity. Additionally, low‐dose sorafenib, alone or combined with R848, normalizes the tumor vasculature, generating a positive feedback loop to support the antitumor immune environment. Therefore, the combination therapy reprograms the HCC immune microenvironment and normalizes the vasculature, improving the therapeutic benefit of low‐dose sorafenib and minimizing toxicity, suggesting a promising novel immunotherapy (R848) and targeted therapy (tyrosine kinase inhibitors) combination strategy for HCC treatment." @default.
- W4366602743 created "2023-04-23" @default.
- W4366602743 creator A5000254398 @default.
- W4366602743 creator A5003414196 @default.
- W4366602743 creator A5003905836 @default.
- W4366602743 creator A5013217019 @default.
- W4366602743 creator A5023214008 @default.
- W4366602743 creator A5036275489 @default.
- W4366602743 creator A5044770364 @default.
- W4366602743 creator A5046862694 @default.
- W4366602743 creator A5052729305 @default.
- W4366602743 creator A5054109175 @default.
- W4366602743 creator A5055815413 @default.
- W4366602743 creator A5071074966 @default.
- W4366602743 creator A5080803689 @default.
- W4366602743 creator A5084591703 @default.
- W4366602743 date "2023-04-21" @default.
- W4366602743 modified "2023-10-18" @default.
- W4366602743 title "The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma" @default.
- W4366602743 cites W1487455823 @default.
- W4366602743 cites W1589935218 @default.
- W4366602743 cites W1965618865 @default.
- W4366602743 cites W1966107523 @default.
- W4366602743 cites W1971324461 @default.
- W4366602743 cites W1971837077 @default.
- W4366602743 cites W1975182142 @default.
- W4366602743 cites W1983634321 @default.
- W4366602743 cites W1996512088 @default.
- W4366602743 cites W2003773886 @default.
- W4366602743 cites W2006517495 @default.
- W4366602743 cites W2015141049 @default.
- W4366602743 cites W2022540958 @default.
- W4366602743 cites W2057555593 @default.
- W4366602743 cites W2062107099 @default.
- W4366602743 cites W2080202443 @default.
- W4366602743 cites W2094935740 @default.
- W4366602743 cites W2098236252 @default.
- W4366602743 cites W2104300873 @default.
- W4366602743 cites W2126980635 @default.
- W4366602743 cites W2128435884 @default.
- W4366602743 cites W2128565827 @default.
- W4366602743 cites W2128627731 @default.
- W4366602743 cites W2131783235 @default.
- W4366602743 cites W2135415260 @default.
- W4366602743 cites W2135556328 @default.
- W4366602743 cites W2136428555 @default.
- W4366602743 cites W2144893998 @default.
- W4366602743 cites W2161540365 @default.
- W4366602743 cites W2166433840 @default.
- W4366602743 cites W2185644008 @default.
- W4366602743 cites W2186246196 @default.
- W4366602743 cites W2237699600 @default.
- W4366602743 cites W2264432295 @default.
- W4366602743 cites W2271479646 @default.
- W4366602743 cites W2530012709 @default.
- W4366602743 cites W2556868315 @default.
- W4366602743 cites W2580579569 @default.
- W4366602743 cites W2587691649 @default.
- W4366602743 cites W2601414401 @default.
- W4366602743 cites W2606151758 @default.
- W4366602743 cites W2606367731 @default.
- W4366602743 cites W2624831627 @default.
- W4366602743 cites W2736365842 @default.
- W4366602743 cites W2783703728 @default.
- W4366602743 cites W2787358630 @default.
- W4366602743 cites W2791328450 @default.
- W4366602743 cites W2796271069 @default.
- W4366602743 cites W2896033748 @default.
- W4366602743 cites W2900144939 @default.
- W4366602743 cites W2922443161 @default.
- W4366602743 cites W2952406594 @default.
- W4366602743 cites W2965242861 @default.
- W4366602743 cites W2974291499 @default.
- W4366602743 cites W2978708928 @default.
- W4366602743 cites W2998269674 @default.
- W4366602743 cites W3002770500 @default.
- W4366602743 cites W3007935255 @default.
- W4366602743 cites W3012491782 @default.
- W4366602743 cites W3026178611 @default.
- W4366602743 cites W3044222890 @default.
- W4366602743 cites W3045299854 @default.
- W4366602743 cites W3045387409 @default.
- W4366602743 cites W3082231031 @default.
- W4366602743 cites W3084409519 @default.
- W4366602743 cites W3093964219 @default.
- W4366602743 cites W3110414417 @default.
- W4366602743 cites W3112760672 @default.
- W4366602743 cites W3128646645 @default.
- W4366602743 cites W3128999657 @default.
- W4366602743 cites W3129833353 @default.
- W4366602743 cites W3134443156 @default.
- W4366602743 cites W3150836655 @default.
- W4366602743 cites W3195791228 @default.
- W4366602743 cites W3212903603 @default.
- W4366602743 cites W3215130238 @default.
- W4366602743 cites W4210774372 @default.
- W4366602743 cites W4210958129 @default.
- W4366602743 cites W4220703268 @default.
- W4366602743 cites W4294804816 @default.
- W4366602743 cites W4366602743 @default.